Peterson Wealth Services Reduces Position in Zoetis Inc. $ZTS

Peterson Wealth Services reduced its position in Zoetis Inc. (NYSE:ZTS) by 93.5% during the second quarter, HoldingsChannel.com reports. The firm owned 1,246 shares of the company’s stock after selling 17,847 shares during the period. Peterson Wealth Services’ holdings in Zoetis were worth $194,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Sage Mountain Advisors LLC raised its holdings in shares of Zoetis by 104.4% in the second quarter. Sage Mountain Advisors LLC now owns 2,976 shares of the company’s stock worth $464,000 after buying an additional 1,520 shares during the period. Moment Partners LLC grew its position in Zoetis by 3.2% in the 2nd quarter. Moment Partners LLC now owns 2,354 shares of the company’s stock valued at $367,000 after acquiring an additional 72 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its position in Zoetis by 0.8% in the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,054,743 shares of the company’s stock valued at $164,487,000 after acquiring an additional 8,541 shares during the last quarter. Jackson Hole Capital Partners LLC increased its stake in Zoetis by 3.2% in the second quarter. Jackson Hole Capital Partners LLC now owns 20,250 shares of the company’s stock worth $3,158,000 after purchasing an additional 625 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its position in Zoetis by 159,400.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 1,595 shares of the company’s stock valued at $249,000 after buying an additional 1,594 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on ZTS. UBS Group reduced their price objective on Zoetis from $165.00 to $158.00 and set a “neutral” rating on the stock in a report on Monday. Leerink Partnrs lowered Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Leerink Partners downgraded Zoetis from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Piper Sandler increased their target price on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. Finally, Argus reissued a “buy” rating and set a $190.00 target price on shares of Zoetis in a research report on Tuesday, September 9th. Four equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Zoetis presently has an average rating of “Hold” and a consensus price target of $195.00.

Zoetis Stock Performance

ZTS stock opened at $146.14 on Friday. Zoetis Inc. has a one year low of $139.34 and a one year high of $184.40. The firm has a market cap of $64.77 billion, a price-to-earnings ratio of 25.15, a PEG ratio of 2.35 and a beta of 0.90. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The firm has a 50-day simple moving average of $148.18 and a two-hundred day simple moving average of $153.50.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The firm had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the previous year, the firm earned $1.56 EPS. The company’s quarterly revenue was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts forecast that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s dividend payout ratio (DPR) is presently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.